Molecular and epidemiological characterization of recurrent Mycobacterium ulcerans infections in Benin.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
12 2021
Historique:
received: 24 06 2021
accepted: 04 12 2021
revised: 10 01 2022
pubmed: 29 12 2021
medline: 17 2 2022
entrez: 28 12 2021
Statut: epublish

Résumé

Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans, an environmental mycobacterium. Although transmission of M. ulcerans remains poorly understood, the main identified risk factor for acquiring Buruli ulcer is living in proximity of potentially contaminated water sources. Knowledge about the clinical features of Buruli ulcer and its physiopathology is increasing, but little is known about recurrence due to reinfection. We describe two patients with Buruli ulcer recurrence due to reinfection with M. ulcerans, as demonstrated by comparisons of DNA from the strains isolated at the time of the first diagnosis and at recurrence. Based on the spatial distribution of M. ulcerans genotypes in this region and a detailed study of the behavior of these two patients with respect to sources of water as well as water bodies and streams, we formulated hypotheses concerning the sites at which they may have been contaminated. Second episodes of Buruli ulcer may occur through reinfection, relapse or a paradoxical reaction. We formally demonstrated that the recurrence in these two patients was due to reinfection. Based on the sites at which the patients reported engaging in activities relating to water, we were able to identify possible sites of contamination. Our findings indicate that the non-random distribution of M. ulcerans genotypes in this region may provide useful information about activities at risk.

Sections du résumé

BACKGROUND
Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans, an environmental mycobacterium. Although transmission of M. ulcerans remains poorly understood, the main identified risk factor for acquiring Buruli ulcer is living in proximity of potentially contaminated water sources. Knowledge about the clinical features of Buruli ulcer and its physiopathology is increasing, but little is known about recurrence due to reinfection.
METHODOLOGY/PRINCIPAL FINDINGS
We describe two patients with Buruli ulcer recurrence due to reinfection with M. ulcerans, as demonstrated by comparisons of DNA from the strains isolated at the time of the first diagnosis and at recurrence. Based on the spatial distribution of M. ulcerans genotypes in this region and a detailed study of the behavior of these two patients with respect to sources of water as well as water bodies and streams, we formulated hypotheses concerning the sites at which they may have been contaminated.
CONCLUSIONS/SIGNIFICANCE
Second episodes of Buruli ulcer may occur through reinfection, relapse or a paradoxical reaction. We formally demonstrated that the recurrence in these two patients was due to reinfection. Based on the sites at which the patients reported engaging in activities relating to water, we were able to identify possible sites of contamination. Our findings indicate that the non-random distribution of M. ulcerans genotypes in this region may provide useful information about activities at risk.

Identifiants

pubmed: 34962930
doi: 10.1371/journal.pntd.0010053
pii: PNTD-D-21-00885
pmc: PMC8746791
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0010053

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Science. 1999 Feb 5;283(5403):854-7
pubmed: 9933171
Biol Cell. 2018 Nov;110(11):237-248
pubmed: 30055020
PLoS Negl Trop Dis. 2015 Nov 30;9(11):e0004158
pubmed: 26618509
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Cell Microbiol. 2005 Jul;7(7):935-43
pubmed: 15953026
BMC Infect Dis. 2013 Sep 05;13:416
pubmed: 24007371
Lancet. 2020 Apr 18;395(10232):1259-1267
pubmed: 32171422
Am J Trop Med Hyg. 2009 Jul;81(1):82-7
pubmed: 19556571
Emerg Infect Dis. 2020 Mar;26(3):491-503
pubmed: 32091371
Commun Biol. 2020 Apr 20;3(1):177
pubmed: 32313116
Lancet Planet Health. 2019 Aug;3(8):e349-e356
pubmed: 31439316
J Clin Microbiol. 2014 Dec;52(12):4398-400
pubmed: 25320228
Immunol Rev. 2021 May;301(1):122-144
pubmed: 33709421
BMC Genomics. 2015 Jun 06;16:434
pubmed: 26048573
PLoS Negl Trop Dis. 2019 Aug 26;13(8):e0007689
pubmed: 31449522
Mol Biol Evol. 2018 Dec 1;35(12):3041-3043
pubmed: 30351396
PLoS Negl Trop Dis. 2021 Aug 26;15(8):e0009678
pubmed: 34437549
One Health. 2021 Aug 18;13:100311
pubmed: 34485670
J Infect Dis. 2015 Apr 1;211(7):1154-63
pubmed: 25336729
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Immunol. 2016 Mar 15;196(6):2690-8
pubmed: 26873988
Clin Microbiol Rev. 2017 Dec 13;31(1):
pubmed: 29237707
Am J Trop Med Hyg. 2004 Oct;71(4):387-92
pubmed: 15516631
Emerg Microbes Infect. 2021 Dec;10(1):223-225
pubmed: 33467983
Lancet Glob Health. 2014 Jul;2(7):e422-30
pubmed: 25103396
Clin Infect Dis. 2011 Jan 1;52(1):94-6
pubmed: 21148526
PLoS Pathog. 2020 Dec 18;16(12):e1009107
pubmed: 33338061
Sci Rep. 2020 Jan 28;10(1):1284
pubmed: 31992776
Am J Trop Med Hyg. 2007 Nov;77(5):834-6
pubmed: 17984337

Auteurs

Ronald Gnimavo (R)

Centre de Diagnostic et de Traitement de l'ulcère de Buruli, Fondation Raoul Follereau, Pobè, Bénin.

Alban Besnard (A)

Univ Angers, Inserm, INCIT, Angers, France.

Horace Degnonvi (H)

Univ Angers, Inserm, INCIT, Angers, France.
Centre Inter Facultaire de Formation et de Recherche en Environnement pour le Développement Durable (CIFRED), Université d'Abomey Calavi (UAC), Cotonou, Benin.

Juliana Pipoli Da Fonseca (J)

Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie, Paris, France.

Marie Kempf (M)

Univ Angers, Inserm, CHU Angers, INCIT, Angers, France.

Christian Roch Johnson (CR)

Centre Inter Facultaire de Formation et de Recherche en Environnement pour le Développement Durable (CIFRED), Université d'Abomey Calavi (UAC), Cotonou, Benin.

Alexandra Boccarossa (A)

Univ Angers, Inserm, INCIT, Angers, France.
CNRS, UMR ESO, Université d'Angers, Angers, France.

Yao Télesphore Brou (YT)

UMR 228 ESPACE-DEV (IRD, UAG, UM, UR), Station SEAS-OI, Saint Pierre, Ile de la Réunion, France.

Laurent Marsollier (L)

Univ Angers, Inserm, INCIT, Angers, France.

Estelle Marion (E)

Univ Angers, Inserm, INCIT, Angers, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH